PRIMARY SJOGREN'S SYNDROME
Clinical trials for PRIMARY SJOGREN'S SYNDROME explained in plain language.
Never miss a new study
Get alerted when new PRIMARY SJOGREN'S SYNDROME trials appear
Sign up with your email to follow new studies for PRIMARY SJOGREN'S SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on childhood arthritis and autoimmune diseases
Disease control Recruiting nowThis study is testing a new treatment using specially engineered immune cells (CAR-T cells) in children aged 5 and older with severe rheumatic diseases like juvenile dermatomyositis, arthritis, systemic sclerosis, and Sjögren's syndrome that haven't improved with standard therapi…
Matched conditions: PRIMARY SJOGREN'S SYNDROME
Phase: PHASE1 • Sponsor: Chongqing Precision Biotech Co., Ltd • Aim: Disease control
Last updated May 26, 2026 04:48 UTC
-
Engineered immune cells take on autoimmune diseases in first human test
Disease control Recruiting nowThis early-phase study tests a new treatment called OL-CD19-GDT, which uses specially engineered immune cells (CAR-T cells) from a healthy donor to target and destroy faulty immune cells in people with severe systemic sclerosis or Sjögren's syndrome that have not responded to sta…
Matched conditions: PRIMARY SJOGREN'S SYNDROME
Phase: PHASE1 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated May 22, 2026 14:03 UTC